Literature DB >> 16052809

[Investigations on the occurrence as well as the role of Demodex follicuforum and Demodex brevis in the pathogensis of blepharitis].

Damian Czepita1, Wanda Kuźna-Grygiel, Danuta Kosik-Bogacka.   

Abstract

PURPOSE: The aim of the paper was to describe the prevalence and the role of Demodex folliculorum and Demodex brevis in the pathogenesis of chronic blepharitis.
MATERIAL AND METHODS: Examinations were carried out on a group of 435 people aged from 3 to 96 years. A sample of four eyelashes were taken aseptically from each individual and later studied under a light microscope. Infection of Demodex was classified on the basis of presence of mature and larval forms or after observing chitinous exuviae affixed to the studied eyelashes.
RESULTS: It has been concluded that Demodex occurs among: 13% of the people aged from 3 to 15 years; 34% of the people aged from 19 to 25 years; 69% of the people aged from 31 to 50 years; 87% of the people aged from 51 to 70 years and 95% of the people aged from 71 to 96 years. It has been observed that 58% of the people infected with Demodex suffer from chronic blepharitis. It was also found that Demodex frequently occurs among people taking care of the elderly and among students of the Medical School.
CONCLUSIONS: (1) Demodex folliculorum and Demodex brevis are an etiological factor in chronic blepharitis. (2) With age the prevalence of infection of Demodex rises. (3) People taking care of the elderly and students of Medical Schools are at higher risk of being infected with Demodex.

Entities:  

Mesh:

Year:  2005        PMID: 16052809

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  8 in total

Review 1.  Ocular Demodicosis as a Potential Cause of Ocular Surface Inflammation.

Authors:  Xiaohui Luo; Jing Li; Chuan Chen; Scheffer Tseng; Lingyi Liang
Journal:  Cornea       Date:  2017-11       Impact factor: 2.651

2.  Demodex treatment in external ocular disease: the outcomes of a Tasmanian case series.

Authors:  Stephen G Nicholls; Carmen L Oakley; Andrea Tan; Brendan J Vote
Journal:  Int Ophthalmol       Date:  2016-02-02       Impact factor: 2.031

3.  Prevalence of Demodex spp. in eyelash follicles in different populations.

Authors:  Maria Wesolowska; Brygida Knysz; Adam Reich; Dominika Blazejewska; Marcin Czarnecki; Andrzej Gladysz; Andrzej Pozowski; Marta Misiuk-Hojlo
Journal:  Arch Med Sci       Date:  2014-05-13       Impact factor: 3.318

Review 4.  Human Permanent Ectoparasites; Recent Advances on Biology and Clinical Significance of Demodex Mites: Narrative Review Article.

Authors:  Dorota Litwin; WenChieh Chen; Ewa Dzika; Joanna Korycińska
Journal:  Iran J Parasitol       Date:  2017 Jan-Mar       Impact factor: 1.012

5.  Terpinen-4-ol is the Most Active Ingredient of Tea Tree Oil to Kill Demodex Mites.

Authors:  Sean Tighe; Ying-Ying Gao; Scheffer C G Tseng
Journal:  Transl Vis Sci Technol       Date:  2013-11-13       Impact factor: 3.283

6.  Age differences in ocular demodicosis: Demodex profiles and clinical manifestations.

Authors:  Jing Li; Xiaohui Luo; Yinglin Liao; Lingyi Liang
Journal:  Ann Transl Med       Date:  2021-05

7.  Molecular Characterization and Analysis of 16S Ribosomal DNA in Some Isolates of Demodex folicullorum.

Authors:  Afrooz Daneshparvar; Gholamreza Mowlavi; Hamed Mirjalali; Homa Hajjaran; Iraj Mobedi; Saeed Reza Naddaf; Mohammadreza Shidfar; Mahsa Sadat Makki
Journal:  Iran J Parasitol       Date:  2017 Apr-Jun       Impact factor: 1.012

8.  In vitro demodicidal activity of commercial lid hygiene products.

Authors:  Alan G Kabat
Journal:  Clin Ophthalmol       Date:  2019-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.